Skip to content

Mickaël Naassïla

7 papers in the library · 121 citations · publishing 2021-2026

Papers

Sort Most recent Most cited

S-ketamine, but not R-ketamine, transiently suppresses front-loaded binge-like alcohol self-administration in male rats

July 12, 2026 Fahd François Hilal, Méléna Dreinaza, Quentin Lebel et al.

Background and Purpose: Ketamine has emerged as a promising treatment candidate for alcohol use disorder (AUD), yet whether its S- and R-enantiomers differentially regulate ongoing binge-like alcohol self-administration remains unknown. We compared the acute and repeated effects of S- and R-ketamine in a chronic binge-like, front-loaded operant alcohol self-administration paradigm. Experimental...

A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology May 1, 2025 Marcus W. Meinhardt, Ivan Skorodumov, Jérôme Jeanblanc et al. 8 citations

The drug development process in psychiatry faces significant challenges due to low reproducibility rates in animal testing, which often leads to translation failures. To address this issue, we introduce a new approach in psychiatric drug development: a preclinical randomized controlled trial (preRCT). To demonstrate its potential utility, we conducted a multi-center preRCT using the alcohol...

Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats

Brain May 4, 2024 Jérôme Jeanblanc, Romain Bordy, Grégory Fouquet et al. 10 citations

Abstract The use of psilocybin to treat alcohol use disorder is very promising, but its mechanisms of action remain poorly understood. We combined behavioural, pharmacological and gene expression analyses to decipher the mechanisms of action of psilocybin, for the first time, when injected into the brain. Male Long Evans rats underwent chronic operant ethanol self-administration before testing...

Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies.

Journal of neural transmission (Vienna, Austria : 1996) May 1, 2024 Fahd François Hilal, Jérôme Jeanblanc, Chloé Deschamps et al. 8 citations

Alcohol use disorder (AUD) is a public health issue that affects millions of people worldwide leading to physical, mental and socio-economic consequences. While current treatments for AUD have provided relief to individuals, their effectiveness on the long term is often limited, leaving a number of affected individuals without sustainable solutions. In this review, we aim to explore two...

[Interest and mechanisms of action of ketamine in alcohol addiction- A review of clinical and preclinical studies].

Biologie aujourd'hui 2023 Fahd Hilal, Jérôme Jeanblanc, Mickaël Naassïla 3 citations

Alcohol Use Disorder (AUD) is a psychiatric condition characterized by chronic and excessive drinking despite negative consequences on overall health and social or occupational functioning. There are currently limited treatment options available for AUD, and the effects size and the response rates to these treatments are often low to moderate. The World Health Organization has identified the...

Acute lysergic acid diethylamide induces a time-dependent shift toward hippocampal control of default mode network reorganization

Fahd François Hilal, Rayane Benkeddada, Jeanblanc Jérôme et al.

Background Classical psychedelics induce profound changes in brain function, yet the temporal organization of these effects remains incompletely understood. Methods We investigated the effects of acute lysergic acid diethylamide (LSD) on large-scale brain connectivity in nine male Long–Evans rats using resting-state functional magnetic resonance imaging. Following a 15-min baseline acquisition,...